SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 33.53-2.8%Nov 12 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert K. who wrote (17010)7/7/2004 12:09:28 PM
From: Bluegreen  Read Replies (1) of 17367
 
Bob, when you have some time look and see if you can find any research on Chemotherapy and anti-lfa-1. Has there been any research on adding anti-lfa-1 to Chemoresistant tumors? So, do you think Raptiva will be the ONLY medicine in history of mankind to be used for only one malady.....moderate to severe Psoriasis?LOL OR, do you think Raptiva will be used for a considerable expanded list of maladies alone or in combination with other meds for the next several decades?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext